Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, Guggenheim Analyst Says

Tempus AI (NASDAQ:TEM - Get Free Report) had its price target lifted by equities research analysts at Guggenheim from $65.00 to $75.00 in a report released on Monday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. Guggenheim's price objective points to a potential upside of 12.75% from the stock's current price.

Several other research firms have also commented on TEM. Bank of America increased their price target on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research report on Wednesday, June 25th. BTIG Research initiated coverage on shares of Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 price objective for the company. Piper Sandler raised their target price on shares of Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a research note on Thursday, May 15th. Morgan Stanley lifted their price target on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a report on Wednesday, May 7th. Six investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $63.67.

Tempus AI Price Performance

NASDAQ TEM opened at $66.52 on Monday. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.56 and a current ratio of 1.71. The firm's 50 day moving average price is $61.26 and its 200-day moving average price is $53.45. Tempus AI has a 52-week low of $30.77 and a 52-week high of $91.45. The company has a market cap of $11.52 billion and a PE ratio of -8.53.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. Tempus AI's quarterly revenue was up 75.4% compared to the same quarter last year. Sell-side analysts forecast that Tempus AI will post -6.15 EPS for the current fiscal year.

Insider Activity

In related news, CEO Eric P. Lefkofsky sold 250,000 shares of the company's stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $70.07, for a total value of $17,517,500.00. Following the sale, the chief executive officer now owns 9,357,283 shares in the company, valued at $655,664,819.81. This represents a 2.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Ryan M. Bartolucci sold 6,073 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $63.23, for a total transaction of $383,995.79. Following the completion of the transaction, the chief accounting officer now owns 47,799 shares in the company, valued at approximately $3,022,330.77. This trade represents a 11.27% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 606,897 shares of company stock valued at $41,261,163 over the last ninety days. 27.60% of the stock is currently owned by insiders.

Institutional Trading of Tempus AI

Several institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. increased its stake in shares of Tempus AI by 6,247.5% in the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock worth $289,204,000 after acquiring an additional 5,900,668 shares during the period. Nikko Asset Management Americas Inc. boosted its holdings in Tempus AI by 166.0% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. ARK Investment Management LLC boosted its holdings in Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after purchasing an additional 1,981,755 shares during the last quarter. Franklin Resources Inc. grew its position in Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after purchasing an additional 1,950,862 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after buying an additional 1,651,996 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.